RAFAEL MARÍA
CANTÓN MORENO

2024

1. A long-term survey of Serratia spp. bloodstream infections revealed an increase of antimicrobial resistance involving adult population

   Microbiology Spectrum, Vol. 12, Núm. 2

2. A multisite validation of a two hours antibiotic susceptibility flow cytometry assay directly from positive blood cultures

   BMC Microbiology, Vol. 24, Núm. 1

3. Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform

   Nature Communications, Vol. 15, Núm. 1

4. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022)

   JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

5. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

   Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Vol. 30, Núm. 2, pp. 223-230

6. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

   Enfermedades Infecciosas y Microbiologia Clinica

7. COVID-19: On the threshold of the fifth year. The situation in Spain

   Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 17-28

8. Corrigendum to “Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia” [International Journal of Infectious Diseases, volume 110 (2021) pages 36-44, (S1201971221005907), (10.1016/j.ijid.2021.07.034)]

   International Journal of Infectious Diseases

9. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022

   International Journal of Antimicrobial Agents, Vol. 63, Núm. 5

10. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

11. Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 7, pp. 1349-1353

12. Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1-Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping

    Microbiology Spectrum, Vol. 12, Núm. 4

13. Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers

    Viruses, Vol. 16, Núm. 2

14. Free PCR virus detection via few-layer bismuthene and tetrahedral DNA nanostructured assemblies

    Talanta, Vol. 269

15. In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77

16. In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 6, pp. 1432-1440

17. In vitro activity of cefiderocolagainst European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations

    Microbiology Spectrum, Vol. 12, Núm. 8

18. In vitro activity of ozenoxacin against Staphylococcus aureus and Streptococcus pyogenes clinical isolates recovered in a worldwide multicentre study (2020-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

19. International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe

    Nature Communications, Vol. 15, Núm. 1

20. Meningococcal meningitis in Spain in the Horizon 2030: A position paper

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 4, pp. 285-298